PMDA drug package insert
ケナリス点鼻薬
PMDA OTC drug · 奥田製薬（株） · package insert Aug 3, 2022
Key facts
| Brand names | ケナリス点鼻薬 |
|---|---|
| Companies | 製造販売元／奥田製薬（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 噴霧剤 |
| OTC effect category | 鼻炎用点鼻薬 |
| Package insert date | Aug 3, 2022 |
| PMDA document key | 180150_J1301000314 |
| PMDA company code | 180150 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: